Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-25-000423
Filing Date
2025-06-13
Accepted
2025-06-13 14:09:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5182
  Complete submission text file 0000935836-25-000423.txt   6903
Mailing Address 467 CENTRAL PARK WEST NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Subject) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88813 | Film No.: 251045740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)